Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
61
CXMSF Quote, Financials, Valuation and Earnings
Last price:
$0.75
Seasonality move
:
-0.33%
Day range:
$0.70 - $0.70
52-week range:
$0.46 - $0.72
Dividend yield:
0.32%
P/E ratio:
7.28x
P/S ratio:
0.64x
P/B ratio:
0.78x
Volume:
--
Avg. volume:
114.8K
1-year change:
1.01%
Market cap:
$10.2B
Revenue:
$16.2B
EPS (TTM):
$0.10
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Cemex SAB de CV has -- downside to fair value with a price target of -- per share.
CXMSF vs. S&P 500
-
Over the past 5 trading days, Cemex SAB de CV has underperformed the S&P 500 by -0.06% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cemex SAB de CV does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cemex SAB de CV revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Cemex SAB de CV reported revenues of $3.6B.
Earnings Growth
-
Cemex SAB de CV has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Cemex SAB de CV reported earnings per share of $0.05.
Enterprise value:
9.3B
EV / Invested capital:
--
Price / LTM sales:
0.64x
EV / EBIT:
6.30x
EV / Revenue:
0.58x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
7.94x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
5.44x
Gross Profit (TTM):
$5.3B
Return On Assets:
5.07%
Net Income Margin (TTM):
8.84%
Return On Equity:
11.36%
Return On Invested Capital:
10.33%
Operating Margin:
8.01%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $15B | $16.8B | $16B | $3.9B | $3.6B | |
| Gross Profit | $4.6B | $5.7B | $5.3B | $1.3B | $1.1B | |
| Operating Income | $1.4B | $2B | $1.7B | $420.7M | $292.2M | |
| EBITDA | $1.4B | $2.1B | $1.7B | $471.1M | $347.5M | |
| Diluted EPS | $0.06 | $0.01 | $0.10 | $0.02 | $0.05 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.7B | -- | $5.2B | $5.2B | $5.4B | |
| Total Assets | $27.6B | -- | $27.5B | $28.6B | $28B | |
| Current Liabilities | $5.4B | -- | $5.6B | $6.7B | $6.2B | |
| Total Liabilities | $18B | -- | $15.7B | $16.5B | $14.6B | |
| Total Equity | $9.6B | -- | $11.8B | $12.1B | $13.4B | |
| Total Debt | $9.7B | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2020-03-31 | 2021-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $1.5B | $1.8B | -$39M | $120M | |
| Cash From Investing | -- | -$198M | $238M | $336M | $487M | |
| Cash From Financing | -- | -$235M | -$2.1B | $337M | -$262M | |
| Free Cash Flow | -$750.1M | $705M | $1.2B | -$182M | -$15M | |
CXMSF
Sector
Market Cap
$10.2B
$19.1M
Price % of 52-Week High
96.8%
70.42%
Dividend Yield
0.32%
0%
Shareholder Yield
--
0.73%
1-Year Price Total Return
1.01%
-6.33%
Beta (5-Year)
1.460
0.736
Dividend yield:
0.32%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.70
200-day SMA
Buy
Level
$0.60
Bollinger Bands (100)
Buy
Level
0.57 - 0.69
Chaikin Money Flow
Buy
Level
17.9K
20-day SMA
Buy
Level
$0.69
Relative Strength Index (RSI14)
Buy
Level
59.10
ADX Line
Buy
Level
14.27
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$0.68
MACD (12, 26)
Buy
Level
0.01
25-day Aroon Oscillator
Sell
Level
-4
On Balance Volume
Neutral
Level
1.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.34)
Sell
CA Score
(Annual)
Level (-0.3058)
Buy
Beneish M-Score
(Annual)
Level (-2.711)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.0506)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cemex is the largest ready-mix concrete company and one of the largest aggregates companies in the world. In 2021, the company sold roughly 67 million tons of cement, 49.2 million cubic meters of ready-mix, and 135 million tons of aggregates. As of Dec. 31, 2021, the company had annual cement production capacity of roughly 88.5 million tons.
Stock Forecast FAQ
In the current month, CXMSF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CXMSF average analyst price target in the past 3 months is --.
-
Where Will Cemex SAB de CV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cemex SAB de CV share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Cemex SAB de CV?
Analysts are divided on their view about Cemex SAB de CV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cemex SAB de CV is a Sell and believe this share price will rise from its current level to --.
-
What Is Cemex SAB de CV's Price Target?
The price target for Cemex SAB de CV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CXMSF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cemex SAB de CV is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CXMSF?
You can purchase shares of Cemex SAB de CV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cemex SAB de CV shares.
-
What Is The Cemex SAB de CV Share Price Today?
Cemex SAB de CV was last trading at $0.75 per share. This represents the most recent stock quote for Cemex SAB de CV. Yesterday, Cemex SAB de CV closed at $0.70 per share.
-
How To Buy Cemex SAB de CV Stock Online?
In order to purchase Cemex SAB de CV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
